期刊文献+

PRKAG2心脏综合征发病机制研究进展

Advances in Research on Pathogenesis of PRKAG2 Cardiac Syndrome
暂未订购
导出
摘要 PRKAG2心脏综合征是一种由于编码单磷酸腺苷激活蛋白激酶γ2亚基的PRKAG2基因遗传性缺陷导致的罕见的常染色体显性遗传病,它的典型表现为:心室预激、进展性传导系统疾病和心脏肥大。虽然PRKAG2心脏综合征的临床表现与肥厚型心肌病、预激综合征相似,但它们在发病机制上却存在着本质的差别,PRKAG2心脏综合征是一种心脏代谢性疾病。现就近年来对PRKAG2心脏综合征发病机制的研究做一综述。 The PRKAG2 cardiac syndrome is an unusual autosomal dominant disease caused by the PRKAG2 genetic defect. This gene encodes the gamma-2 regulatory subunit of AMP-activated protein kinase. PRKAG2 cardiac syndrome is a cardiac metabolic disease. This article reviews recent research regarding the pathogenesis of PRKAG2. PRKAG2 cardiac syndrome is characterized by ventricular preexcitation, progressive conduction system disease, and cardiac hypertrophy. Although the clinical phenotype of the PRKAG2 cardiac syndrome is similar to hypertrophic cardiomyopathy and Wolff-Parkinson-White syndrom,there is essential distinction on the pathogenesis among them. The PRKAG2 cardiac syndrome is a cardiac metabolic disease. This article reviews current research on the pathogenesis of the PRKAG2 cardiac syndrome.
出处 《心血管病学进展》 CAS 2012年第1期42-45,共4页 Advances in Cardiovascular Diseases
关键词 PRKAG2心脏综合征 机制 PRKAG2 cardiac syndrome pathogenesis
  • 相关文献

参考文献2

二级参考文献13

  • 1Gollob MH, Seger JJ, Gollob TN,et al. Novel PRKAG2 mutation in the genetic syndrome of ventricular preexcitation and conduction defects with childhood onset and absence of cardiac hypertrophy.Circulation, 2001,104(25) :3030-3033.
  • 2Blair E, Redwood C, Ashrafian H, et al. Mutations in the gamma (2) subunit of AMP activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis. Hum Mol Genet,2001,10 ( 11 ) : 1215-1220.
  • 3Gollob MH, Green MS, Tang A, et al. Identification of a gene responsible for familial Wolff-Parkinson-White syndrome. N Engl J Med,2001,344(24) :1823-1864.
  • 4Marian AJ, Roberts,s R. The molecular genetic basis for hypertrophic cardiomyopathy. J Mol Cell Cardiol, 2001,33 ( 4 ) :655-670.
  • 5Sternick EB, Oliva A, Magalhaes LP, et al. Familial pseudo-Wolff-Parkinson-White syndrome. J Cardiovasc Electrophysiol,2006,17 (7) :724-732.
  • 6Arad M, Benson DW, Perez-Atayde AB, et al. Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy. J Clin Invest, 2002,109(3) :357-362.
  • 7Laforet P, Richard P, Said MA, et al. A new mutation in PRKAG2 gene causing hypertrophic cardiomyopathy with conduction system disease and muscular glycogenosis.Neuromuscul Disord,2006,16(3 ) : 178-182.
  • 8Khair GZ, Soni GS, Bamrah VS. Syncope in hypertrophic cardiomyopathy Ⅱ. coexistence of atrioventricular block and Wolff-Parkinson-White syndrome. Am Heart J, 1985,110 ( 5 ) : 1083-1086.
  • 9Mac Rae CA, Ghaisas N, Kass S, et al. Familial hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome maps to a locus on chromosome 7q3. J Clin Invest, 1995,96 ( 3 ) : 1216- 1220.
  • 10Gollob MH, Green MS, Tang ASL, et al. Identification of a gene responsible for familial Wolff-Parkinson-White syndrome. N Engl J Med ,2001,344 ( 24 ) : 1823-1831.

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部